Hemostasis (coagulation and fibrinolysis) is of importance in a broad range of medical disciplines. A high-quality hemostasis diagnosis enables a good therapy, which can be rather complicated without laboratory help. This yearbook gathers important contributions in this field and presents them in a coherent and logical format.

Platelets are essential mediators of the physiologic process of hemostasis and pathologic thrombosis. While platelets do not interact with vascular walls under normal conditions, vascular injury or inflammation result in a coordinated series of events including platelet adhesion, aggregation, and promotion of coagulation. In this review, we describe the primary mechanisms involved in these responses in various vascular beds of both macro- and microvessels, and outline key unresolved aspects of these important interactions.Table of Contents: Introduction / General Characteristics of Platelets / Platelet Adhesion to Vascular Walls / Platelet Aggregation / Platelet Recruitment and Blood Coagulation / Arterial, Venous, and Microvascular Hemostasis/Thrombosis / Summary

Preview this title's catalog page in a new window 100 Questions & Answers About Von Willerbrand Disease First Edition Second Edition Third Edition Fourth Edition Fifth Edition Sixth Edition Seventh Edition Eighth Edition Ninth Edition Tenth Edition Eleventh Edition Twelve Edition Authors: Andra H. James , MD , Duke University Medical Center Show degrees: Yes No Show affiliations: Yes No ISBN: 0763757675 ISBN-13: 9780763757670 Price: $17.95 Binding: Paperback Pages: 114 Link for Request Review Copy: http://www.jbpub.com/cart/compcart.cfm?bc=5767-0&t= Will Publish: 05/21/2008 Copyright: Title Page Text [Edit] EMPOWER YOURSELF! The only text to provide both the patient's and doctor's views, 100 Questions & Answers About Von Willebrand Disease provides a much needed primer for patients and their families. This book address the questions most relevant to those recently diagnosed with the disease, offering up-to-date, authoritative, practical, yet easy to understand answers to your questions about Von Willebrand Disease, including indispensable information about diagnosis and treatment. VWD is a common bleeding disorder, affecting 1% of all people; this valuable resource will help those diagnosed better understand and cope with the disorder.

For the most honest, objective opinion, HealthScouter provides a patient's view of the most common medical problems. Including hundreds of quotes, questions, and answers from patients themselves, this guide provides comprehensive information about a single condition for from perspective that matters: the patient's perspective. Understand how current patients approach their medical challenges, and help overcome your own. This reference will help you see through obscure medical jargon and limited treatment options and empower you to better understand the issues that really matter: Diagnosis + Symptoms + What to Expect + Treatment Options + Medical Terminology

In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more. Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more. Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.

The Oxford Handbook of Clinical Haematology continues to provide the essential knowledge needed in modern clinical practice for the diagnosis and management of patients with disorders of the blood. Major advances in the specialty, primarily within the malignant haematology area, have been reflected in this thoroughly revised new edition. Agencies such as NICE have influenced the prescribing of chemotherapeutic and other related drugs, and there have also been updates from the British Committee for Standards in Haematology and other guidelines for malignant disease, thrombosis and haemostasis.
This Handbook includes the main differential diagnoses and relevant investigations that will help junior doctors to arrive at a definitive diagnosis. The management of the patient is provided in a way that allows the junior to initiate treatment while waiting for review of the patient by a senior member of staff. A bestselling Oxford Handbook, this is the indispensable companion for all those caring for patients with blood disorders.

This book will assist pathologists, hematologists, and oncologists in interpreting peripheral blood and bone marrow specimens quickly, easily, and accurately. Featuring more than 400 full-color illustrations, the book is a very complete survey of bone marrow diseases, including rare entities, and provides up-to-date information on constitutional and acquired disorders in both adults and children. This edition includes the latest information on hematologic and associated diseases, including many new disease descriptions, recent genetic and immunologic findings, and the current World Health Organization classification of hematolymphoid disorders.

A companion Website will offer the fully searchable text and an image bank.

Cutting-edge scientific breakthroughs in treating hemophilia, including gene therapy and recombinant DNA technology, are described. Symptoms of the disease are also detailed, providing a clear picture of what it is like to live with this royal disease.

This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.

This scarce antiquarian book is included in our special Legacy Reprint Series. In the interest of creating a more extensive selection of rare historical book reprints, we have chosen to reproduce this title even though it may possibly have occasional imperfections such as missing and blurred pages, missing text, poor pictures, markings, dark backgrounds and other reproduction issues beyond our control. Because this work is culturally important, we have made it available as a part of our commitment to protecting, preserving and promoting the world's literature.

Presenting the new edition of the classic reference on paediatric haematology and oncology, this book, comprehensively revised and updated, continues to integrate lucid reviews of the pathophysiology of disease with detailed clinical guidance on its diagnosis and management. Drs. Nathan and Orkin - joined by two new co-editors and an outstanding team of authors - worked tirelessly to ensure that all the latest scientific advances appear in the sixth edition.

A-Z of Haematology provides an essential 'quick reference guide' to definitions covering the entire spectrum of haematology, from blood transfusion and coagulation through to recent advances in molecular haematology.

It is the indispensable guide for all those practising or studying haematology including research scientists and biomedical scientists working in diagnostic laboratories. Scientists working in cytogenetics and immunophenotyping will also find it a valuable repository of relevant knowledge.

A-Z of Haematology includes:
Definitions cover the entire spectrum of haematology, from blood transfusion and coagulation through to molecular haematology
Essential "quick reference guide" for all those practising or studying haematology
Over 100 figures to explain and clarify difficult concepts
Inclusion of all CD numbers and oncogenes to be encountered in daily practice
Appendices of laboratory data and normal values included

Das 7. Heidelberger Symposium A1/4ber HAmostaseologie in der AnAsthesiologie hatte als zentrales Thema die disseminierte Gerinnungsaktivierung, wie sie bei Sepsis im Rahmen der Verbrauchskoagulopathie immer noch ein wichtiges klinisches Problem ist. Die disseminierte Gerinnungsaktivierung stellt sich immer wieder mit zwei Gesichtern dar: Zum einen ist sie ein Paradepferd der wissenschaftlichen HAmostaseologie, das Modell, an dem die Gerinnung erforscht wird, zum anderen ist sie immer wieder fA1/4r EnttAuschungen und Aoeberraschungen gut, denn kaum meint man, ein MolekA1/4l und seine Wirkung verstanden zu haben, so lehrt die klinische Erfahrung, dass dies nicht so einfach ist, wie man ursprA1/4nglich dachte.

Understanding the connections between culture, race, politics, and disease This groundbreaking book chronicles the history of sickle cell anemia in the United States, tracing its transformation from an ""invisible"" malady to a powerful, yet contested, cultural symbol of African American pain and suffering. Set in Memphis, where one of the nation's first sickle cell clinics was founded in the 1950s, Dying in the City of the Blues reveals how the recognition, treatment, social understanding, and symbolism of the disease evolved in the twentieth century, shaped by the politics of race, region, health care, and biomedicine. Using medical journals, patients' accounts, black newspapers, blues lyrics, and many other sources, Keith Wailoo follows the disease and its sufferers from the early days of obscurity before sickle cell's ""discovery"" by Western medicine; through its rise to clinical, scientific, and social prominence in the 1950s; to its politicization in the 1970s and 1980s. Looking forward, he considers the consequences of managed care on the politics of disease in the twenty-first century. A rich and multilayered narrative, Dying in the City of the Blues offers valuable new insight into the African American experience, the impact of race relations and ideologies on health care, and the politics of science, medicine, and disease.

Hemoglobin has been involved in the most significant advances in our understanding of modern genetics and molecular biology. Now, hemoblobin is again central to a new area: development of artificial blood (blood substitute.) This volume of Methods in Enzymology and its companion, Volume 232, will be indispensable to anyone with a serious interest in this emerging field. They completely update and extend the information presented in Volume 76 published a decade ago.
Key Features
* Preparation, purification, and analysis of human hemoglobin and of various non-human hemoglobins
* Preparation of hemoglobin hybrids and of model heme compounds
* Preparation of chemically modified hemoglobins and of recombinant hemoglobins
* Analytical procedures presented for studying hemoglobin stability and degradation and for the formation of xenobiotic adducts of hemoglobin

There are today five major proteins in plasma fractioning. In the near future, other fractions could also be used as therapeutic agents. But perhaps they could be used for alternative, non-therapeutic applications? For example, producing human culture media with specific ingredients for biotechnology research might also be of use. Whatever the future may hold, there is one essential question: in today's world of cellular and genetic engineering, are extracted therapeutic proteins still of any relevance? For a clear and up-to-date view of recent developments in blood-protein-separation technology, this book will prove an invaluable resource.

With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis. This trusted resource by Drs. Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, Michael B. Streiff, and David A. Garcia is designed for rapid reference and critical decision making at the point of care. Emphasizes real-world problems and solutions, with quick access to concise descriptions of each condition, associated symptoms, laboratory findings, differential diagnosis, and treatment. Features a user-friendly design, full-color format, abundant laboratory protocols, and at-a-glance tables and charts throughout. Provides thorough updates on core information on hemostasis and thrombosis, including deep venous thrombosis (DVT), pulmonary embolisms, hypercoagulability, thrombocytopenia, von Willenbrand disease, and more. Covers new treatment information on hemophilia A and B. Contains new chapters on hereditary hemorrhagic telangiectasia, hemolytic uremic syndrome, and paroxymal nocturnal hemoglobinuria. Two new editors, Dr. Michael B. Streiff and Dr. David A. Garcia, offer fresh perspectives and valuable experience. Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

This title includes proceedings of the first European Symposium on platelet immunology held in Paris, Palais du Luxembourg (France), 1 to 2 March 1990.

This book provides a highly illustrated and comprehensive account of the diseases of the human bone marrow. It will help experienced clinicians and those in training to answer the practical diagnostic questions that arise during the routine analysis of bone marrow core biopsy specimens. Throughout the text, histologic interpretation is integrated with clinical and laboratory findings. Emphasis is placed on the evaluation of peripheral blood, aspirate smear, clot section and core biopsy, as well as ancillary techniques including flow cytometry and immunohistochemistry in the diagnosis of hematologic disorders of the marrow. The text is illustrated with numerous color figures, charts and tables, and descriptions of real case situations using the most up-to-date classification systems. Illustrated Pathology of Bone Marrow should be read by all pathologists, hematologists and laboratory technicians involved in the analysis of bone marrow specimens.

Zur Untersuchung des Einflusses von tubularem HIF auf die renale EPO-Produktion generierte Navid Farsijani ein genetisches Mausmodell, in dem durch tubulare Vhl-Ablation, tubulare Epithelzellen HIF uberexprimieren. Die tubulare Vhl-Ablation fuhrte zu einer prompten Suppression der renalen EPO-Produktion. Anhand weitere konditioneller Mausmodelle zeigt der Autor, dass die Entwicklung der Anamie von HIF-abhangig ist, proximale Tubuluszellen fur die Regulation von EPO im Nephron verantwortlich sind und die tubulare Vhl-Ablation mit einer Reduktion der mitochondrialen Masse sowie einer Erhoehung des kortikalen Gewebssauerstoffpartialdruckes (PtO2) einhergeht. Dies spricht fur eine multi-zellulare Regulation der renalen EPO-Synthese, in der eine Homoeostase zwischen tubularen Epithelzellen und REPC fur eine adaquate EPO-Produktion der Niere notwendig ist. Zudem koennte der EPO-suppressive Effekt von tubularem HIF einen pathophysiologischen Faktor in der Entstehung von renalen Anamien darstellen.

The authors summarise advances in human pluripotent stem cells-derived erythroid development and molecular regulatory mechanisms. This research may provide a new perspective on human embryo erythropoiesis and a possible treatment for some hematological diseases. Erythrocytes are well equipped to carry out their functions due to a dynamic cell membrane, their inherent shape and lack of organelles and cytoplasmic viscosity. As such, the following section focusses on the causes of these modifications and their clinical implications. As an example of complexity in research towards the development of erythrocyte membrane-based drug delivery systems starting from animal erythrocyte, morphological, biochemical and drug release profiles will be reviewed in the penultimate chapter. The final chapter investigates the electrochemical behavior of erythrocytes at platinum, carbonaceous, and optically transparent electrodes via polarization and coulometric measurements. The order of magnitude of the quantity of electrons transferred between erythrocytes and electrodes was determined, and potential ranges showing indifference of the electrode toward red blood cells were identified.

Hemostasis involves a set of strictly regulated processes that maintain blood in its fluid state within the vascular bed and, in case of vessel injury, promote the formation of platelet plugs and fibrin clots to prevent blood extravasation. As such, Platelets: Overview, Function and Disorders explores how platelets play an important role in the blood coagulation process, and how platelet deficiencies or functional defects may be the cause of some bleeding disorders. The worldwide incidence of cutaneous melanoma has been increasing annually at a more rapid rate in comparison to any other type of cancer affecting predominantly young and middle-aged individuals. It is known that when melanoma cells leave the primary tumor and enter the blood stream, they activate surrounding platelets via some molecules, inducing microthrombus formation. The authors discuss how platelets contribute to inflammation, cancer invasion, and metastasis. Additionally, the role of platelet-rich-plasma in stimulating the healing process in difficult-to-heal ulcers has been investigated over the past 25 years. It is suggested that platelet-rich-plasma is capable of transforming the difficult-to-heal skin ulcer with low metabolic activity into a healing ulcer with increased capacity for tissue regeneration. This closing study focuses on the causes, diagnosis, and prognosis of various types of thrombocytopenia, providing an outline on the future prospects of using antioxidants for the treatment of a few thrombocytopenic conditions.

1m Verlauf der in den letzten Jahren und Jahrzehnten erzielten groBen Fortschritte der Pathophysiologie der BluteiweiBe wurde die Analyse der Plasmaproteine zu einem der aktuellsten Kapitel der modernen klinischen Laboratoriumsdiagnostik. Neben den Methoden der direkten chemischen und elektrophoretischen EiweiBbestimmung ist es vor allem das Phano- men der krankheitsbedingten Kolloidstabilitatsveranderung von Serum und Plasma, dessen diagnQstische Nutzbarmachung mit einem tiber- waltigenden Arbeitsaufwand von seiten zahlloser Forscher vorangetrie- ben wurde und standig weiter ausgebaut wird. Die hierbei beschrittenen Wege sind vielfaltig; sie entsprangen zum Teil sehr unterschiedlichen Fragestellungen und dienten den verschiedenartigsten praktischen Zwek- ken. Die Reihe der so im Laufe der Zeit fUr diagnostische Aufgaben in der Klinik (Leberfunktionsprtifung, Aktivitatsfeststellung bei Tuber- kulose und anderen entztindlichen Erkrankungen, Karzinomdiagnostik usw. ) entwickelten Kolloid-Labilitatsreaktionen des Blutes umfaBt be- reits tiber 250 Methoden. Die mit ihnen gesammelten Erkenntnisse brachten eine beachtliche Ausweitung unseres Wissens tiber die Humoral- pathologie des Blutes. Trotzdem ist das allgemeine Urteil tiber diesen Zweig der klinischen Diagnostik auch heute noch bemerkenswert un- einheitlich, und es bestehen tiber die wirkliche Leistungsfiihigkeit der sogenannten Labilitatsreaktionen vielerorts falsche Vorstellungen. Es sind dabei aIle Auffassungen zu finden von einer kritiklosen Dberschat- zung einerseits bis zur grundsatzlichen Ablehnung dieser Methoden an- dererseits. Infolge der Beteiligung fast aller Facher der Medizin an der Entwicklung der Kolloidstabilitatsdiagnostik des Blutes und der dadurch weit verstreuten einschlagigen Literatur ist die Verschaffung eines um- fassenderen Dberblicks tiber dieses Gebiet nicht einfach.